2008
DOI: 10.1007/s00213-008-1200-1
|View full text |Cite
|
Sign up to set email alerts
|

DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis

Abstract: Our findings suggest that exogenous NO benefits chronic stress-induced depression by stimulating hippocampal neurogenesis and may represent a novel approach for the treatment of depressive disorders.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0
1

Year Published

2011
2011
2016
2016

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 62 publications
0
20
0
1
Order By: Relevance
“…In this same line of evidence, treatment with antidepressives causes a decrease in NO production in cerebral cortex and hippocampus [24]. On the other hand, administration of a NO donor reversed chronic mild stress-induced behavioral despair and impairment in hippocampal neurogenesis in mice [19,23].…”
Section: Introductionmentioning
confidence: 94%
See 1 more Smart Citation
“…In this same line of evidence, treatment with antidepressives causes a decrease in NO production in cerebral cortex and hippocampus [24]. On the other hand, administration of a NO donor reversed chronic mild stress-induced behavioral despair and impairment in hippocampal neurogenesis in mice [19,23].…”
Section: Introductionmentioning
confidence: 94%
“…Recent studies, both in humans [18] and in animal models [19][20][21][22][23], suggest an involvement of endogenous hippocampal nitric oxide (NO) in the neurobiology of stress and depression. Intra-hippocampal administration of nitric oxide synthase (NOS) inhibitors induce antidepressant-like effects in rodents [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…Conversely, L-NNA, depending on its dose is able to cause an antidepressant-like effect, which can be reversed by l-arginine, administered at a dose that produces no effect in the FST (da Silva et al 2000). Interestingly, exogenous administration of l-arginine (250-500 mg/kg), at same doses that produce anti-immobility effect, increased neuronal NO signal (Heinzen and Pollack 2002) and DETA/NONOate, a NO donor, produces antiimmobility effect associated with enhancement of NO x levels and hippocampal neurogenesis (Hua et al 2008). Accordingly, a low dose of L-NAME (100 mg/kg, ip) decreased the immobility time in the FST, whereas high doses (175-300 mg/kg, ip) did not produce any anti-immobility effect in the FST (Harkin et al 1999).…”
Section: Discussionmentioning
confidence: 90%
“…Likewise, the prior administration of 7-nitroindazole and the iNOS inhibitor aminoguanidine significantly reduced the number of BrdU ϩ cells in the dentate gyrus after pentylenetrazol-induced seizures in the adult rat brain (55), supporting a role for NO in brain repair after brain injury or seizures. DETA/NONOate has also been shown to produce antidepressant effects by promoting hippocampal neurogenesis in young adult mice (56). The explanation for these paradoxical effects of NO lie in the existence and differential effects of the NOS isoforms and/or the FIGURE 6.…”
Section: Discussionmentioning
confidence: 99%